COLUMBIA, Md.--(BUSINESS WIRE)--July 31, 2006--CELSION CORPORATION (AMEX:CLN - News) today announced that, in accordance with the terms of an agreement reached in August 2005 between Celsion and Boston Scientific (NYSE:BSC - News), Boston Scientific has advanced the third and final installment of a US$15 million loan to Celsion. Dr. Lawrence Olanoff, Celsion's Chief Executive Officer, commented, "We are very pleased that Boston Scientific has released the final installment of this loan as it demonstrates their continuing satisfaction with the progress that has been made with Prolieve. We believe that based on current plans, our cash on hand together with income generated from Prolieve sales should be sufficient to fund the current phase of our development programs through 2007."
